All Stories

  1. Revolutionizing cancer treatment: Nanotherapeutics targeting the tumor micro-environment
  2. Ferroptosis and iron homeostasis in chronic obstructive pulmonary disease: Therapeutic opportunities of iron chelators
  3. Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer’s and Parkinson’s disease
  4. Current Landscape of Novel Therapeutic Agents and Drug Targets in Irritable Bowel Syndrome
  5. Box–Behnken-designed nanostructured lipid carriers of xanthohumol for enhanced cellular uptake in human lung cancer cell line A549: formulation, optimization, characterization, and cytotoxicity assessment
  6. Investigating the Therapeutic Potential of Agarwood Nanoemulsion in Modulating TGF-β-Induced Airway Remodelling in BEAS-2B Cells
  7. Liposomal drug delivery system for lung diseases: Recent advancement and future perspectives
  8. One-step synthesis of TiO2@MWCNT by plasma reactor for wastewater purification
  9. Comparative assessment of antibiofilm and antioxidant activities between curcuma longa silver nano particles and ethanolic extract of curcuma longa
  10. Cost-effective synthesis of magnesium hydroxide and magnesium oxide by arc discharge method: Comparative studies for their biological activities
  11. Cellular senescence in chronic obstructive pulmonary disease: Molecular mechanisms and therapeutic interventions
  12. Functional crosstalk between the lung and eye: a new frontier in chronic lung diseases
  13. Exploring Protein Aggregation in Biological Products: From Mechanistic Understanding to Practical Solutions
  14. Algal bioactives: Unlocking future frontiers in respiratory therapeutics
  15. Exosomal delivery of non-coding RNAs: a pathway to apoptosis regulation in lung cancer
  16. Targeting oncogenic signaling pathways in lung Cancer: The emerging role of nobiletin, a flavonoid from citrus peel
  17. Advances in Alzheimer's therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape
  18. Unravelling the role of nanomedicine in attenuating inflammation, oxidative stress and cellular ageing in chronic obstructive pulmonary disease
  19. Exploring natural components in vaccine delivery systems: Types, routes of administration, in-vitro and in-vivo quantification techniques
  20. From nature to nanotech: Unlocking Berberine's therapeutic approaches
  21. Application of Self-Nanoemulsifying Drug Delivery Systems in Inflammatory Diseases
  22. Investigating the Harmful Effects of Bushfire Smoke Exposure in Precision Cut Lung Slices
  23. Predicting Motif-Mediated Interactions Based on Viral Genomic Composition
  24. Central composite designed boswellic acids loaded nanoparticles for enhanced cellular uptake in human lung cancer cell line A549
  25. Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects
  26. Does drug repurposing bridge the gaps in management of Parkinson’s disease? Unravelling the facts and fallacies
  27. A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes
  28. Potent phytoceuticals cocktail exhibits anti-inflammatory and antioxidant activity on LPS-triggered RAW264.7 macrophages in vitro
  29. From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease
  30. Multifunctional Plumeria rubra nanoparticles: Antimicrobial, antiviral, antiparasitic and anti-inflammatory activities
  31. Nanotechnology-Driven Treatment Strategies for Breast Cancer: Recent Advances and Innovations
  32. Interplay of nano-based delivery systems and protein signalling in ameliorating lung diseases
  33. The impact of airborne particulate matter-based pollution on the cellular and molecular mechanisms in chronic obstructive pulmonary disease (COPD)
  34. Non-coding RNA: A key regulator in the Glutathione-GPX4 pathway of ferroptosis
  35. Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer
  36. Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review
  37. Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are?
  38. Cellular probing using phytoceuticals encapsulated advanced delivery systems in ameliorating lung diseases: Current trends and future prospects
  39. Unlocking the future of osteoarthritis: Material engineering and drug delivery confluence for advanced therapeutic approaches
  40. Therapeutic potential of 18-β-glycyrrhetinic acid-loaded poly (lactic-co-glycolic acid) nanoparticles on cigarette smoke-induced in-vitro model of COPD
  41. Revolutionizing Eye Care: Exploring the Potential of Microneedle Drug Delivery
  42. Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives
  43. Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects
  44. Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape
  45. The antiparasitic effect of C-Phycocyanin nanoparticles on cryptosporidiosis in immunosuppressed mice
  46. Liposomal encapsulated curcumin attenuates lung cancer proliferation, migration, and induces apoptosis
  47. Chungtaejeon (CTJ) inhibits adhesion and migration of VSMC through cytoskeletal remodeling pathway
  48. Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies
  49. Innovative phytoceutical-based drug delivery in the management of pulmonary fibrosis: A roadmap towards inhaled therapeutics
  50. Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices
  51. Liposomal curcumin inhibits cigarette smoke induced senescence and inflammation in human bronchial epithelial cells
  52. Fecal microbiome extract downregulates the expression of key proteins at the interface between airway remodelling and lung cancer pathogenesis in vitro
  53. Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance
  54. Mesenchymal stem cell membrane-coated nanoconstructs: why have they not yet found a home in clinical practice?
  55. Effectiveness of phytoconstituents and potential of phyto-nanomedicines combination to treat osteoarthritis
  56. Exploring the role of the ocular surface in the lung-eye axis: Insights into respiratory disease pathogenesis
  57. ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease
  58. Revolutionizing Eye Care: Exploring the Potential of Microneedle Drug Delivery
  59. Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
  60. Exploring the anti-inflammatory and anti-fibrotic activity of NFκB decoy oligodeoxynucleotide-loaded spermine-functionalized acetalated nanoparticles
  61. In silico design and evaluation of a multiepitope vaccine targeting the nucleoprotein of Puumala orthohantavirus
  62. Exploring the current advancements of quercetin nanoformulations alleviating respiratory diseases
  63. Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases
  64. 18-β-Glycyrrhetinic acid encapsulated PLGA nanoparticles attenuate lung cancer proliferation and migration
  65. 18-β-glycyrrhetinic acid-loaded polymeric nanoparticles attenuate cigarette smoke-induced markers of impaired antiviral response in vitro
  66. Curcumin-loaded liposomes modulating the synergistic role of EpCAM and estrogen receptor alpha in lung cancer management
  67. The impact of formaldehyde exposure on lung inflammatory disorders: Insights into asthma, bronchitis, and pulmonary fibrosis
  68. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer
  69. Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges
  70. Exploring Viral–Host Protein Interactions as Antiviral Therapies: A Computational Perspective
  71. RETRACTED ARTICLE: Polysaccharide-fecal microbiota-based colon-targeted self-nanoemulsifying drug delivery system of curcumin for treating polycystic ovarian syndrome
  72. Prediction of virus–host interactions and identification of hot spot residues of DENV-2 and SH3 domain interactions
  73. Uncovering domain motif interactions using high‐throughput protein–protein interaction detection methods
  74. TSANZ Abstracts
  75. Futuristic Senolytic Drug Incorporated Nanomedicine Therapy to Treat Osteoarthritis
  76. Opening avenues for treatment of neurodegenerative disease using post-biotics: Breakthroughs and bottlenecks in clinical translation
  77. Prediction of motif-mediated viral mimicry through the integration of host–pathogen interactions
  78. Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives
  79. The application of nanoparticles as advanced drug delivery systems in Attenuating COPD
  80. Proteome‐wide assessment of human interactome as a source of capturing domain–motif and domain‐domain interactions
  81. Immunotherapy Against Lung Cancer
  82. Antioxidant genes in cancer and metabolic diseases: Focusing on Nrf2, Sestrin, and heme oxygenase 1
  83. Knowledge on Chemical Pesticide use among Farmers Exposed to Pesticides in Panchkhal Municipality, Kavrepalanchok, Nepal
  84. Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles
  85. Liposomal Encapsulated Curcumin Attenuates Lung Cancer Proliferation, Migration and Apoptosis
  86. Ribavirin attenuates carcinogenesis by downregulating IL-6 and IL-8 in vitro in human lung adenocarcinoma
  87. Bioinformatics prediction and screening of viral mimicry candidates through integrating known and predicted DMI data
  88. Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease
  89. Dissecting the in vitro fate of plant-derived bioactive encapsulated nanoparticles in lung diseases
  90. Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
  91. Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases
  92. A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response
  93. Agarwood oil nanoemulsion counteracts LPS-induced inflammation and oxidative stress in RAW264.7 mouse macrophages
  94. Inhalation drug delivery in combating pulmonary infections: Advances and challenges
  95. Zerumbone liquid crystalline nanoparticles protect against oxidative stress, inflammation and senescence induced by cigarette smoke extract in vitro
  96. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells
  97. In vitro anti-cancer activity of a polyherbal preparation, VEDICINALS®9, against A549 human lung adenocarcinoma cells
  98. The potent synergistic effect of Brassica oleracea against congenital Toxoplasma infection in rat model
  99. Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
  100. An overview of biomedical applications for gold nanoparticles against lung cancer
  101. Front Cover Image, Volume 43, Issue 5
  102. Cigarette smoking induces lung cancer tumorigenesis via upregulation of the WNT/β-catenin signaling pathway
  103. Unravelling the role of solid lipid nanoparticles in drug delivery: Journey from laboratory to clinical trial
  104. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro
  105. Antidiabetic evaluation of vanillic acid-glyburide loaded polymeric micelles in high fat diet and streptozotocin induced diabetic rats
  106. Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition in lung adenocarcinoma
  107. Role of Flavonoids in Management of Various Biological Targets in Alzheimer’s Disease: Evidence from Preclinical to Clinical Studies
  108. Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases
  109. Advanced models for respiratory disease and drug studies
  110. Exploring the Remarkable Chemotherapeutic Potential of Polyphenolic Antioxidants in Battling Various Forms of Cancer
  111. Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology
  112. Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives
  113. Anticancer activity of NFκB decoy oligonucleotide-loaded nanoparticles against human lung cancer
  114. Tackling the cytokine storm using advanced drug delivery in allergic airway disease
  115. Design and synthesis of novel bis-pyridinium based-ionic liquids as potent antiparasitic agents
  116. Progress on Understanding Metabolic Syndrome, and Knowledge of Its Complex Pathophysiology
  117. Agarwood Oil Nanoemulsion Attenuates Cigarette Smoke-Induced Inflammation and Oxidative Stress Markers in BCi-NS1.1 Airway Epithelial Cells
  118. The Pandemic and Your Skin—Direct and Indirect Impact of COVID-19
  119. Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling
  120. The significance of quercetin-loaded advanced nanoformulations for the management of diabetic wounds
  121. Targeting vascular inflammation in atherosclerosis with plant extracts, phytochemicals, and their advanced drug formulations
  122. Synbiotics for the Management of Cancer
  123. Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
  124. Bioactive Compounds from the Plants of the Elaeodendron Genus and Their Biological Activities—A Review
  125. Phytantriol-Based Berberine-Loaded Liquid Crystalline Nanoparticles Attenuate Inflammation and Oxidative Stress in Lipopolysaccharide-Induced RAW264.7 Macrophages
  126. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases
  127. Prevalence and Factors Associated with Tobacco Use among High School Students
  128. Targeting the mitochondria in chronic respiratory diseases
  129. Vitamin D—A prominent immunomodulator to preventCOVID‐19 infection
  130. Anti-Influenza Virus Potential of Probiotic Strain Lactoplantibacillus plantarum YML015 Isolated from Korean Fermented Vegetable
  131. Nutraceuticals and COVID‐19: A mechanistic approach toward attenuating the disease complications
  132. The Emerging Role of Pericyte-Derived Extracellular Vesicles in Vascular and Neurological Health
  133. Advancements in nanotherapeutics targeting senescence in chronic obstructive pulmonary disease
  134. Formulation and Development of Adapalene Topical Nanohydrogel Using Different Surfactants and Cosurfactants for Antiacne Activity: In Vitro and Ex Vivo Evaluation
  135. Unravelling the Therapeutic Potential of Nano-Delivered Functional Foods in Chronic Respiratory Diseases
  136. Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis
  137. Advances in research with rutin-loaded nanoformulations in mitigating lung diseases
  138. Recent advances in lung-on-a-chip models
  139. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems
  140. Stinging Nettle (Urtica dioica L.): Nutritional Composition, Bioactive Compounds, and Food Functional Properties
  141. Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases
  142. Polymeric micelles loaded with glyburide and vanillic acid: I. Formulation development, in-vitro characterization and bioavailability studies
  143. Advances and applications of dextran-based nanomaterials targeting inflammatory respiratory diseases
  144. Topical non-aqueous nanoemulsion of Alpinia galanga extract for effective treatment in psoriasis: In vitro and in vivo evaluation
  145. Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma
  146. A kNGR Peptide-Tethered Lipid–Polymer Hybrid Nanocarrier-Based Synergistic Approach for Effective Tumor Therapy: Development, Characterization, Ex-Vivo, and In-Vivo Assessment
  147. Adverse roles of mast cell chymase-1 in chronic obstructive pulmonary disease
  148. Role of oxidative stress in the pathogenesis of COPD
  149. Editorial: Pharmacology of Plant Polyphenols in Human Health and Diseases
  150. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation
  151. Journey of Alpinia galanga from kitchen spice to nutraceutical to folk medicine to nanomedicine
  152. Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives
  153. “Nanodecoys” - Future of drug delivery by encapsulating nanoparticles in natural cell membranes
  154. Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine–Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro
  155. Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases
  156. Applications of extracellular vesicles as a drug-delivery system for chronic respiratory diseases
  157. Expanding the arsenal against pulmonary diseases using surface-functionalized polymeric micelles: breakthroughs and bottlenecks
  158. Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 Cells
  159. ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
  160. Dressing multifunctional nanoparticles with natural cell-derived membranes for superior chemotherapy
  161. Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems
  162. Treating primary lymphoma of the brain in AIDS patients via multifunctional oral nanoparticulate systems
  163. Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models
  164. Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro
  165. Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases
  166. Phytochemicals and their Nanoformulations Targeted for Pulmonary Diseases
  167. Epigenetic Therapy as a Potential Approach for Targeting Oxidative Stress–Induced Non-small-Cell Lung Cancer
  168. Role of autoimmunity in the pathogenesis of chronic obstructive pulmonary disease and pulmonary emphysema
  169. The science of matcha: Bioactive compounds, analytical techniques and biological properties
  170. Recent Advances in Chronotherapy Targeting Respiratory Diseases
  171. Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases
  172. Bioactive Compounds from Zingiber montanum and Their Pharmacological Activities with Focus on Zerumbone
  173. Berberine-Loaded Liquid Crystalline Nanoparticles Inhibit Non-Small Cell Lung Cancer Proliferation and Migration in Vitro
  174. Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases
  175. Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro
  176. Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases
  177. Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases
  178. Mitochondrial dysfunctions associated with chronic respiratory diseases and their targeted therapies: an update
  179. Versatility of liquid crystalline nanoparticles in inflammatory lung diseases
  180. Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro
  181. Current-status and applications of polysaccharides in drug delivery systems
  182. The FBXW7‐NOTCH interactome : A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues
  183. Drug delivery advances in mitigating inflammation via matrix metalloproteinases in respiratory diseases
  184. Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation
  185. Targeting Cancer using Curcumin Encapsulated Vesicular Drug Delivery Systems
  186. Liensinine Prevents Vascular Inflammation by Attenuating Inflammatory Mediators and Modulating VSMC Function
  187. Genus Blepharis (Acanthaceae): A review of ethnomedicinally used species, and their phytochemistry and pharmacological activities
  188. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives
  189. Tea (Catechins Including (−)-Epigallocatechin-3-gallate) and Cancer
  190. Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease
  191. Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier Based Drug Delivery Systems
  192. MicroRNAs as Biomarker for Breast Cancer
  193. Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection
  194. Anti‐inflammatory and anticancer activities of Naringenin‐loaded liquid crystalline nanoparticles in vitro
  195. Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549
  196. Rutin loaded liquid crystalline nanoparticles inhibit lipopolysaccharide induced oxidative stress and apoptosis in bronchial epithelial cells in vitro
  197. Microparticles-Mediated Vascular Inflammation and its Amelioration by Antioxidant Activity of Baicalin
  198. Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
  199. The GSK-3β-FBXL21 Axis Contributes to Circadian TCAP Degradation and Skeletal Muscle Function
  200. Smooth Muscle Cell Derived Microparticles Acts as Autocrine Activation of Smooth Muscle Cell Proliferation by Mitogen Associated Protein Kinase Upregulation
  201. Impact of bushfire smoke on respiratory health
  202. Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective
  203. Molecular mechanisms of action of naringenin in chronic airway diseases
  204. Incipient need of targeting airway remodeling using advanced drug delivery in chronic respiratory diseases
  205. Eriobotrya japonica leaf extract attenuates airway inflammation in ovalbumin-induced mice model of asthma
  206. Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update
  207. Recent advances in experimental animal models of lung cancer
  208. Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases
  209. Targeting lung cancer using advanced drug delivery systems
  210. Vascular Protection by Ethanol Extract of Morus alba Root Bark: Endothelium-Dependent Relaxation of Rat Aorta and Decrease of Smooth Muscle Cell Migration and Proliferation
  211. Phytochemical profile and pharmacological activity of Aegle marmelos Linn.
  212. Anticancer Activity ofPunica granatum(Pomegranate): A Review
  213. Phytochemical profile and biological activity of Juglans regia
  214. Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7
  215. Alkaloid rich fraction from Nelumbo nucifera targets VSMC proliferation and migration to suppress restenosis in balloon-injured rat carotid artery
  216. Chungtaejeon, a Korean fermented tea, prevents the risk of atherosclerosis in rats fed a high-fat atherogenic diet
  217. Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression
  218. Reactive Oxygen Species: A Key Hallmark of Cardiovascular Disease
  219. Antiatherogenic Effect ofCamellia japonicaFruit Extract in High Fat Diet-Fed Rats
  220. Phytochemical Profile and Biological Activity ofNelumbo nucifera
  221. Terminalia chebulaFructus Inhibits Migration and Proliferation of Vascular Smooth Muscle Cells and Production of Inflammatory Mediators in RAW 264.7
  222. Preventive Effect of Traditional Korean Formulations on Intimal Thickening of Rat Carotid Artery Injured by Balloon Catheter